HOME >> BIOLOGY >> NEWS
Structure of enzyme offers treatment clues for diabetes, Alzheimer's

Researchers from the University of Chicago and Argonne National Laboratory have deciphered the three-dimensional structure of insulin-degrading enzyme, a promising target for new drugs because it breaks down not only insulin but also the amyloid-beta protein, which has been linked to the cognitive decline of Alzheimer's disease.

In the October 19, 2006, issue of Nature (available online Oct. 11), the researchers describe the structures of insulin-degrading enzyme (IDE) in complex with four of the proteins it digests: insulin, amyloid-beta, amylin and glucagon. The structures are exciting because they suggest ways to develop drugs that could either speed up or slow down this ubiquitous enzyme's activity.

"The structure of insulin-degrading enzyme tells us a lot about how it works, which is somewhat unorthodox," said Wei-Jen Tang, Ph.D., associate professor in the Ben May Institute for Cancer Research at the University of Chicago and director of the study. "Understanding how it works gives us clues about how to design drugs either to inhibit or activate it."

"By introducing small, targeted mutations, we have already been able to increase the enzyme's activity by as much as 40-fold," he said. "That gives us a blueprint for the next step, trying to devise a drug that would produce a similar effect."

Ever since I. Arthur Mirsky discovered IDE in 1949, physicians have sought ways to manipulate it. Mirsky thought that by inhibiting the enzyme he could help diabetics by making their insulin remain active longer. More recently, as scientists realized that IDE was also involved in clearance of amyloid-beta, they have begun searching for ways to supercharge the enzyme to see if it could prevent the build-up of the amyloid plaques that are a hallmark of Alzheimer's disease.

Despite more than half a century of intensive research, however, insulin-degrading enzyme has remained "an especially elusive pharmacological targe
'"/>

Contact: John Easton
John.Easton@uchospitals.edu
773-702-6241
University of Chicago Medical Center
11-Oct-2006


Page: 1 2 3

Related biology news :

1. International Conference on Modern Bamboo Structures Oct. 11-17
2. Structure of iron regulatory protein-RNA complex solved
3. Self-assembling nano-ice discovered at UNL -- Structure resembles DNA
4. Structure determined for key molecular complex involved in long-term gene storage
5. Structure of key enzyme in plague bacterium found
6. Structure determined for p53 tumor suppressor protein as bound to DNA for anti-cancer activity
7. Structures of marine toxins provide insight into their effectiveness as cancer drugs
8. Breakthrough: Structure of membrane protein described by Hebrew University, German researchers
9. Structure-building cell signals also may influence learning, memory
10. Structure of new DNA enzyme family member found
11. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/28/2020)... PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... to solving complex problems for life sciences companies and government agencies, announced that ... life sciences hubs in the country. Tunnell’s Cambridge office will be in the ...
(Date:1/27/2020)... ... ... On Thursday, February 20, 2020 at 10am EST (3pm GMT/UK), join Gary ... Castle, Global Account Manager Medical Device at PRISYM ID for an informative ... deadlines, best practices in creating and submitting product data and best practices in preparing ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a microbiome research ... announced that the company will debut a novel new DNA isolation kit at the ... product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit designed for ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant ... surgery industry at two recent North American investor forums specializing in medical advancements. ... Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
(Date:1/7/2020)... (PRWEB) , ... January 07, 2020 , ... ... antibody products and services, today announced the launch of its VivopureX™ recombinant mouse ... antibody clones, many originally obtained from rats or hamsters, which Absolute Antibody has ...
(Date:12/31/2019)... (PRWEB) , ... December 31, 2019 , ... ... in expanding its pharmaceutical product development lab in Maryland. Emphasis will ... increased size and expanded capabilities, Vici Health Sciences will be well positioned to ...
Breaking Biology Technology:
Cached News: